Skip to content
Screener
Pharvaris logo

Pharvaris

PHVS

Pharvaris is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Berndt Modig, with a market cap of $2.2B.

Market cap
$2.18B+47.3%

We’re still putting together Pharvaris’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Pharvaris up the queue, and we’ll analyze its filings next.

Earnings

Q2 2026 report

August 12, 2026

Next report

Nov 11, 2026 (in a month)
Revenue estimate$2.3M
EPS estimate-$0.82

Profile

Listed2021
Employees82.0
CEOBerndt Modig
FilingsSEC EDGAR